Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Russell

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Human Gene Therapy|April 25, 2000
A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand displayA K Fielding, S Chapel-Fernandes, M P Chadwick, et al.
Blood|June 5, 2001
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient miceD Grote, S J Russell, T I Cornu, et al.
Blood|July 9, 1999
Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteinsM Maurice, S Mazur, F J Bullough, et al.
Gene Therapy|March 22, 2008
Heat shock protein inhibitors increase the efficacy of measles virotherapyC Liu, C Erlichman, C J McDonald, et al.
Cancer Gene Therapy|June 6, 2009
Dynamics of multiple myeloma tumor therapy with a recombinant measles virusD Dingli, C Offord, R Myers, et al.
Immunohematology|September 18, 2004
Anti-Mta associated with three cases of hemolytic disease of the newbornC C Cheung, D Challis, G Fisher, et al.
Gene Therapy|April 6, 2012
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic virusesK-W Peng, R Myers, A Greenslade, et al.
Brain Research Bulletin|May 6, 1999
Complement depletion does not reduce brain injury in a rabbit model of thromboembolic strokeS M Lew, C E Gross, M M Bednar, et al.
Lancet (London, England)|February 22, 1986
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malariaC S Hatton, T E Peto, C Bunch, et al.
Gene Therapy|July 29, 2003
Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteasesR M Schneider, Y Medvedovska, I Hartl, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Human Gene Therapy|April 25, 2000
A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand displayA K Fielding, S Chapel-Fernandes, M P Chadwick, et al.
Blood|June 5, 2001
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient miceD Grote, S J Russell, T I Cornu, et al.
Blood|July 9, 1999
Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteinsM Maurice, S Mazur, F J Bullough, et al.
Gene Therapy|March 22, 2008
Heat shock protein inhibitors increase the efficacy of measles virotherapyC Liu, C Erlichman, C J McDonald, et al.
Cancer Gene Therapy|June 6, 2009
Dynamics of multiple myeloma tumor therapy with a recombinant measles virusD Dingli, C Offord, R Myers, et al.
Immunohematology|September 18, 2004
Anti-Mta associated with three cases of hemolytic disease of the newbornC C Cheung, D Challis, G Fisher, et al.
Gene Therapy|April 6, 2012
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic virusesK-W Peng, R Myers, A Greenslade, et al.
Brain Research Bulletin|May 6, 1999
Complement depletion does not reduce brain injury in a rabbit model of thromboembolic strokeS M Lew, C E Gross, M M Bednar, et al.
Lancet (London, England)|February 22, 1986
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malariaC S Hatton, T E Peto, C Bunch, et al.
Gene Therapy|July 29, 2003
Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteasesR M Schneider, Y Medvedovska, I Hartl, et al.
Pageof 17